Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Respiratory mucosa, alteration

Ozolek JA, Hunt JL. Tumor suppressor gene alterations in respiratory epithelial adenomatoid hamartoma (REAH) comparison to sinonasal adenocarcinoma and inflamed sinonasal mucosa. Am J Surg Pathol. 2006 30(12) 1576-1580. [Pg.286]

HUMAN HEALTH RISKS Acute Risks irritation of skin, eyes and respiratory system hemorrhage of lungs, small intestine and liver mucous membrane irritation vomiting chest pain emphysema and edema Chronic Risks alters genetic material damage to nasal mucosa and the urinary bladder effects on eyes, skin, respiratory system, liver and kidneys. [Pg.75]

Modification of the pharmacokinetics through structural alterations has provided several new steroids with a better GR affinity and therapeutic index and a lower bioavailability than the older drugs (Fig. 33.14). The new inhaled/intranasal glucocorticosteroids like mometasone furoate, budesonide and fluticasone propionate are more lipophilic than those used in oral and systemic therapy and have greater affinity for the GR than does dexamethasone as a consequence of their greater lipophilicity (43). Several of the topical corticosteroids, such as mometasone furoate, BDP, triamcinolone acetonide, and flunisolide, were reintroduced as inhalation and intranasal dosage forms for treatment of respiratory diseases (e.g., asthma or rhinitis). Inhaled budesonide and flunisolide are readily absorbed from the airway mucosa into the blood and are rapidly biotransformed in the liver into inactive metabolites. Mometasone furoate and fluticasone propionate are very potent anti-inflammatory steroids with an oral bioavailability of less than 1%. Obviously, the risk of systemic side effects for these newer corticosteroids is greatly reduced when compared with ... [Pg.1335]

The biological actions of capsaicin are primarily attributable to release of the neuropeptide substance P, calcitonin gene-related peptide (CGRP), and neurokinin A from sensory neurons. These transmitters from primary sensory neurons communicate witir other cell types. They produce alterations in the airway mucosa and neurogenic inflammation of the respiratory epithelium, airway blood vessels, glands, and smooth muscle. Alterations in multiple effector organs lead to bronchoconstriction, increased vascular permeability, edema of the tracheobronchial mucosa, elevated mucosal secretion, and neutrophil chemotaxis (Tominack and Spyker, 1987). Capsaicin-induced effects of bronchoconstriction, vasodilation, and plasma protein extravasation are mediated by substance P. In addition, substance P can cause bronchoconstriction through stimulation of c-fibers in pulmonary and bronchial circulation. [Pg.138]


See other pages where Respiratory mucosa, alteration is mentioned: [Pg.183]    [Pg.37]    [Pg.218]    [Pg.1]    [Pg.759]    [Pg.52]    [Pg.139]    [Pg.127]    [Pg.219]    [Pg.759]    [Pg.399]    [Pg.56]    [Pg.160]    [Pg.512]    [Pg.55]    [Pg.10]    [Pg.111]    [Pg.159]   
See also in sourсe #XX -- [ Pg.183 ]




SEARCH



Mucosa

Respiratory mucosa

© 2024 chempedia.info